Desmopressin as a potential treatment for stroke due to intracerebral haemorrhage in people taking antiplatelet drugs.
Find out the DASH trial results here: https://t.co/Fn2Y66fYC7 This includes the publication, results video, infographic & lay summary.
Thanks to all involved!
Everyone from the STU, Nottingham would like to send our sincerest thanks to our sites for all your hard work and support of our Stroke Trials during 2022.
We hope you all have a relaxing and enjoyable Christmas and look forward to continue working with you in 2023!
Recruitment has officially closed! With 54 patients being recruited into the trial, exceeding the original target of 50. Thank you to all our sites involved in the trial @NikolaSprigg @mike_desborough
CALLING ALL ATTENDING THE UKSF: Join our CIs on 2nd Dec who will be discussing our 4 newly funded trials here at UoN Stroke Trials Unit and our ongoing trial DASH.
TICH-3 (Tranexamic acid for IntraCerebral Haemorrhage 3):
TICH-3 seeks to assess the clinical effectiveness of tranexamic acid (TXA) after intracerebral haemorrhage, and determine whether TXA should be used in clinical practice.
https://t.co/ZaDrSQvQlB
MAPS-2 (Metoclopramide for Avoiding Pneumonia after Stroke 2):
MAPS-2 is a single-blind, randomised controlled trial of metoclopramide for the prevention of pneumonia in patients with dysphagia after an acute stroke.
https://t.co/OAsMhWGOYm
On #WorldStrokeDay we are highlighting the importance of knowing the signs of stroke and seeking emergency medical care. Face drooping, arm weakness, speech difficulty means time to get emergency medical help. Every second counts, save brain cells, save #Precioustime